156 related articles for article (PubMed ID: 33857831)
1. Generation of a human induced pluripotent stem cell line from a Bietti crystalline corneoretinal dystrophy patient with CYP4V2 mutations.
Wu S; Zhu T; Sun Z; Wei X; Han X; Zou X; Sui R
Stem Cell Res; 2021 May; 53():102330. PubMed ID: 33857831
[TBL] [Abstract][Full Text] [Related]
2. Identification of CYP4V2 mutation in 36 Chinese families with Bietti crystalline corneoretinal dystrophy.
Yin X; Yang L; Chen N; Cui H; Zhao L; Feng L; Li A; Zhang H; Ma Z; Li G
Exp Eye Res; 2016 May; 146():154-162. PubMed ID: 26971461
[TBL] [Abstract][Full Text] [Related]
3. New compound heterozygous CYP4V2 mutations in bietti crystalline corneoretinal dystrophy.
Wang T; Chen Q; Yao X; Kuang L; Gan R; Wang J; Yan X
Gene; 2021 Jul; 790():145698. PubMed ID: 33964374
[TBL] [Abstract][Full Text] [Related]
4. Novel mutations in
Meng XH; He Y; Zhao TT; Li SY; Liu Y; Yin ZQ
Mol Vis; 2019; 25():654-662. PubMed ID: 31741654
[TBL] [Abstract][Full Text] [Related]
5. Genotype and Ocular Phenotype in Sixteen Chinese Patients with Bietti Corneoretinal Crystalline Dystrophy.
Dai H; Zhang Y; Li R; Li Y; Li G
Curr Eye Res; 2022 Mar; 47(3):436-442. PubMed ID: 34724870
[TBL] [Abstract][Full Text] [Related]
6. [Progress in the studies of molecular genetics in Bietti crystalline corneoretinal dystrophy].
Xu F; Sui RF; Dong FT
Zhonghua Yan Ke Za Zhi; 2012 Oct; 48(10):948-51. PubMed ID: 23302251
[TBL] [Abstract][Full Text] [Related]
7. Identification of novel CYP4V2 genotypes associated with Bietti crystalline dystrophy and atypical anterior segment phenotypes in Spanish patients.
García-García GP; Martínez-Rubio M; Moya-Moya MA; Pérez-Santonja JJ; Escribano J
Acta Ophthalmol; 2018 Nov; 96(7):e865-e873. PubMed ID: 29691984
[TBL] [Abstract][Full Text] [Related]
8. Bietti crystalline corneoretinal dystrophy associated with CYP4V2 gene mutations.
Nakamura M; Lin J; Nishiguchi K; Kondo M; Sugita J; Miyake Y
Adv Exp Med Biol; 2006; 572():49-53. PubMed ID: 17249554
[TBL] [Abstract][Full Text] [Related]
9. Identification of CYP4V2 mutation in 21 families and overview of mutation spectrum in Bietti crystalline corneoretinal dystrophy.
Xiao X; Mai G; Li S; Guo X; Zhang Q
Biochem Biophys Res Commun; 2011 Jun; 409(2):181-6. PubMed ID: 21565171
[TBL] [Abstract][Full Text] [Related]
10. Identification and population history of CYP4V2 mutations in patients with Bietti crystalline corneoretinal dystrophy.
Jiao X; Li A; Jin ZB; Wang X; Iannaccone A; Traboulsi EI; Gorin MB; Simonelli F; Hejtmancik JF
Eur J Hum Genet; 2017 Apr; 25(4):461-471. PubMed ID: 28051075
[TBL] [Abstract][Full Text] [Related]
11. Recessive mutations in the CYP4V2 gene in East Asian and Middle Eastern patients with Bietti crystalline corneoretinal dystrophy.
Lin J; Nishiguchi KM; Nakamura M; Dryja TP; Berson EL; Miyake Y
J Med Genet; 2005 Jun; 42(6):e38. PubMed ID: 15937078
[TBL] [Abstract][Full Text] [Related]
12. AAV-mediated gene-replacement therapy restores viability of BCD patient iPSC derived RPE cells and vision of Cyp4v3 knockout mice.
Jia R; Meng X; Chen S; Zhang F; Du J; Liu X; Yang L
Hum Mol Genet; 2023 Jan; 32(1):122-138. PubMed ID: 35925866
[TBL] [Abstract][Full Text] [Related]
13. Longitudinal characterisation of function and structure of Bietti crystalline dystrophy: report on a novel homozygous mutation in
Lockhart CM; Smith TB; Yang P; Naidu M; Rettie AE; Nath A; Weleber R; Kelly EJ
Br J Ophthalmol; 2018 Feb; 102(2):187-194. PubMed ID: 28698241
[TBL] [Abstract][Full Text] [Related]
14. Novel mutations in the CYP4V2 gene associated with Bietti crystalline corneoretinal dystrophy.
Shan M; Dong B; Zhao X; Wang J; Li G; Yang Y; Li Y
Mol Vis; 2005 Sep; 11():738-43. PubMed ID: 16179904
[TBL] [Abstract][Full Text] [Related]
15. CHOROIDAL AND RETINAL ATROPHY OF BIETTI CRYSTALLINE DYSTROPHY PATIENTS WITH CYP4V2 MUTATIONS COMPARED TO RETINITIS PIGMENTOSA PATIENTS WITH EYS MUTATIONS.
Miyata M; Hata M; Ooto S; Ogino K; Gotoh N; Morooka S; Hasegawa T; Hirashima T; Sugahara M; Kuroda Y; Yamashiro K; Yoshimura N
Retina; 2017 Jun; 37(6):1193-1202. PubMed ID: 27658286
[TBL] [Abstract][Full Text] [Related]
16. In vivo genome editing via CRISPR/Cas9-mediated homology-independent targeted integration for Bietti crystalline corneoretinal dystrophy treatment.
Meng X; Jia R; Zhao X; Zhang F; Chen S; Yu S; Liu X; Dou H; Feng X; Zhang J; Wang N; Xu B; Yang L
Nat Commun; 2024 May; 15(1):3773. PubMed ID: 38710738
[TBL] [Abstract][Full Text] [Related]
17. AAV2-mediated gene therapy for Bietti crystalline dystrophy provides functional CYP4V2 in multiple relevant cell models.
Wang JH; Lidgerwood GE; Daniszewski M; Hu ML; Roberts GE; Wong RCB; Hung SSC; McClements ME; Hewitt AW; Pébay A; Hickey DG; Edwards TL
Sci Rep; 2022 Jun; 12(1):9525. PubMed ID: 35680963
[TBL] [Abstract][Full Text] [Related]
18. Presence of corneal crystals confirms an unusual presentation of Bietti's retinal dystrophy.
Song WK; Clouston P; MacLaren RE
Ophthalmic Genet; 2019 Oct; 40(5):461-465. PubMed ID: 31638456
[No Abstract] [Full Text] [Related]
19. An In-Depth Single-Gene Worldwide Carrier Frequency and Genetic Prevalence Analysis of CYP4V2 as the Cause of Bietti Crystalline Dystrophy.
Hanany M; Yang RR; Lam CM; Beryozkin A; Sundaresan Y; Sharon D
Transl Vis Sci Technol; 2023 Feb; 12(2):27. PubMed ID: 36795063
[TBL] [Abstract][Full Text] [Related]
20. Comprehensive screening of
Zhang X; Xu K; Dong B; Peng X; Li Q; Jiang F; Xie Y; Tian L; Li Y
Mol Vis; 2018; 24():700-711. PubMed ID: 30429639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
